The processes by which the DDX41 mutation contributes to the oncogenesis that leads to myeloid neoplasms (MNs) have been investigated, but the underlying molecular pathogenesis of DDX41 mutations in B lymphoblastic leukemia (B-ALL) has not been revealed. This evidence concerns the gene DDX41 and myeloid neoplasm.